These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15153869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
    Deming FP, Al-Hashimi I, Haghighat N, Hallmon WW, Kerns DG, Abraham C, Rivera-Hidalgo F.
    J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
    Ramos-Casals M, Brito-Zerón P, Sisó A, Vargas A, Ros E, Bove A, Belenguer R, Plaza J, Benavent J, Font J.
    J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of soluble CD44 in primary Sjögren's syndrome.
    Levesque MC, Mackin DA, Fleming JA, St Clair EW.
    J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
    [Abstract] [Full Text] [Related]

  • 6. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
    Moody M, Zipp M, Al-Hashimi I.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
    Hammi AR, Al-Hashimi IH, Nunn ME, Zipp M.
    J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
    [Abstract] [Full Text] [Related]

  • 9. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE.
    Cancer Res; 2004 Sep 15; 64(18):6814-9. PubMed ID: 15375001
    [Abstract] [Full Text] [Related]

  • 12. Sex hormone ratio changes in men and postmenopausal women with coronary artery disease.
    He H, Yang F, Liu X, Zeng X, Hu Q, Zhu Q, Tu B.
    Menopause; 2007 Sep 15; 14(3 Pt 1):385-90. PubMed ID: 17108845
    [Abstract] [Full Text] [Related]

  • 13. The significance of salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with Sjögren's syndrome.
    Boras VV, Cikes N, Lukac J, Cekić-Arambasin A, Virag M, Bosnjak A.
    Coll Antropol; 2004 Sep 15; 28 Suppl 2():305-9. PubMed ID: 15571105
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Periodontal status and sulcular Candida albicans colonization in patients with primary Sjögren's Syndrome.
    Rhodus NL, Michalowicz BS.
    Quintessence Int; 2005 Mar 15; 36(3):228-33. PubMed ID: 15887508
    [Abstract] [Full Text] [Related]

  • 17. Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care.
    Leung KC, McMillan AS, Cheung BP, Leung WK.
    Oral Dis; 2008 Mar 15; 14(2):163-73. PubMed ID: 18302677
    [Abstract] [Full Text] [Related]

  • 18. Sjögren's syndrome induced by estrogen therapy.
    Nagler RM, Pollack S.
    Semin Arthritis Rheum; 2000 Dec 15; 30(3):209-14. PubMed ID: 11124284
    [Abstract] [Full Text] [Related]

  • 19. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL, Boumediene A, Lalloue F, Gondran G, Loustaud-Ratti V, Vidal E, Jauberteau MO.
    Scand J Rheumatol; 2009 Dec 15; 38(1):50-7. PubMed ID: 18830907
    [Abstract] [Full Text] [Related]

  • 20. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
    Márka M, Bessenyei B, Zeher M, Semsei I.
    Scand J Immunol; 2005 Nov 15; 62(5):474-80. PubMed ID: 16305644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.